Navigation Links
One Million Americans Now Receive Personalized FDA Drug Safety Alerts Through iGuard.org
Date:12/30/2008

Today, iGuard.org, a free and secure medication monitoring service, registered its one-millionth member just 14 months after its launch last year. iGuard.org’s rapid growth highlights the growing trend toward patients taking a more active role in managing their own healthcare.

PRINCETON, N.J. (Business Wire EON) December 30, 2008 -- Helping Patients and Physicians

"Despite enormous investment of time and money in healthcare information technology, patients don't feel confident that the healthcare system is watching out for them," said Hugo Stephenson, MD, iGuard.org's founder. "iGuard.org is a really simple service. With most Americans getting their prescriptions from many different doctors, iGuard.org enables patients to register their medications for monitoring and sends them customized email drug safety reports, safety alerts and recalls from a pharmacist as new and personally relevant information emerges."

Barbara Munroe of Phoenix, Ariz. is an iGuard.org member who has epilepsy and takes numerous medications. "After wasting away for a year with no energy, I registered all my medicines on iGuard.org," said Munroe. "To my surprise, I soon received an alert about an interaction between Paxil and another medication I'm taking, Zonegran. Since deleting Paxil from my medications my energy has soared. Without iGuard.org's information, I would still be on the couch -- or worse. It has saved my life."

The iGuard.org Service

iGuard.org maintains an up-to-date database of drug-drug and drug-disease interactions, including feeds from the U.S. Food and Drug Administration (FDA) and major drug manufacturers, to provide users with personalized drug safety reports, safety alerts and product recalls by email. Since iGuard.org pharmacists write and review all alerts for a consumer audience, patients receive unders
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
3. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
4. 1.5 million children could be saved
5. The Philadelphia Walk Now for Autism Expected to Draw 10,000 Walkers and Raise $1 Million to Help Find Answers About the Nations Fastest-Growing Developmental Disorder
6. UVa researcher awarded $3.6 million grant to fight drug-resistant bacteria
7. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
8. R. P. Simmons Family Foundation Pledges $2 Million for New Childrens Hospital of Pittsburgh of UPMC Campus
9. £5 million investment in personalized medicines to cut patient deaths
10. Keane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care Facility
11. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 One Million Americans Now Receive Personalized FDA Drug Safety Alerts Through iGuard.org 
(Date:9/17/2014)... North Central Surgical Center is proud to announce ... top-notch services. The hospital was the recipient for several ... , Hospital-wide, North Central was the recipient of the ... award for two years in a row (2013-2014). They ... nation for Patient Safety in 2014 and ranked among ...
(Date:9/17/2014)... blood test that measures DNA from a prostate cancer ... the state of a man,s disease, a new study ... could reveal when treatment for advanced prostate cancer ... researchers suggested. "Our study showed that a steroid ... often initially very effective started to activate harmful mutations ...
(Date:9/17/2014)... New York, New York (PRWEB) September 17, 2014 ... ) filings involving the Conserve line of metal-on-metal ... litigation now underway in U.S. District Court, Northern ... to an updated Case List issued by the ... 15, 2014, at least 397 product liability claims ...
(Date:9/17/2014)... Why are Asian Americans at higher risk of ... to develop the disease at lower body weights? One ... from traditional high-fiber, low-fat Asian diets to current westernized ... Asian heritage, says George King, M.D., Senior Vice President ... the senior author of the study. , A Joslin ...
(Date:9/17/2014)... London, UK (PRWEB) September 17, 2014 ... of the total medical technology market, focusing on molecular ... cancer, chronic diseases, and genetic testing. The IVD market ... billion by the end of 2017. The major drivers ... testing; need for speed, which is evidenced by the ...
Breaking Medicine News(10 mins):Health News:North Central Surgical Center Receives Several Accolades 2Health News:DNA Blood Test Might Identify Status of Prostate Cancer 2Health News:Wright Hip Lawsuit News: Nearly 400 Filings Reported in Federal Wright Conserve Hip Replacement Litigation, Bernstein Liebhard LLP Reports 2Health News:Wright Hip Lawsuit News: Nearly 400 Filings Reported in Federal Wright Conserve Hip Replacement Litigation, Bernstein Liebhard LLP Reports 3Health News:In Joslin trial, Asian Americans lower insulin resistance on traditional diet 2Health News:In Joslin trial, Asian Americans lower insulin resistance on traditional diet 3Health News:World In Vitro Diagnostics Market Analysed by VPG in In-demand Research Report Available at MarketPublishers.com 2Health News:World In Vitro Diagnostics Market Analysed by VPG in In-demand Research Report Available at MarketPublishers.com 3
... explain the increased cases , FRIDAY, Nov. 6 (HealthDay News) ... people at higher risk of getting a type of thyroid ... related to cancer, but researchers suspect that the toxic compounds ... also unsure of why thyroid cancer rates are rising around ...
... a sneeze, people worry more about flu, heart attacks, accidents and ... may sound hard to believe, but just one sneeze is enough ... of dying from a heart attack at an early age, dying ... new research shows. , Of greater concern, however, was that people ...
... Nov. 6 HeartWare International, Inc. (Nasdaq: ... provider of less invasive, miniaturized circulatory support technologies revolutionizing ... it is scheduled to make presentations at two upcoming ... be made at the Third Annual Canaccord Adams Cardiovascular ...
... ... Award. , ... LA (PRWEB) November 6, 2009 -- Gilsbar, a national leader in health benefit ... was recently honored with Platinum-Level recognition for the American Heart Association Start! Fit-Friendly Companies ...
... ... and the recently released World Alzheimer Report declares that more than 35 million people ... innovator with 16 independent living and assisted living, and Alzheimer,s/memory care communities in Wisconsin ... of Alzheimer,s disease. , ...
... Tobacco-Free Kids, American Cancer Society, American Cancer Society Cancer ... American Legacy Foundation , WASHINGTON, Nov. 5 ... judge in Kentucky today rejected a motion by tobacco ... giving the U.S. Food and Drug Administration (FDA) the ...
Cached Medicine News:Health News:Thyroid Cancer Higher in Volcanic Areas 2Health News:Health Fears Are Nothing to Sneeze At 2Health News:Health Fears Are Nothing to Sneeze At 3Health News:HeartWare to Present at Upcoming Investment Conferences in November 2Health News:Gilsbar is Sole Louisiana Company to Win National Award from the American Heart Association 2Health News:Top 10 Ways to Prevent or Delay Alzheimer's 2Health News:Federal Judge Rejects Tobacco Companies' Effort to Block Key Provisions of New Tobacco Regulation Law 2
(Date:9/17/2014)...  Lightbeam Health Solutions announced today an agreement ... ACO) to deploy the Lightbeam population health platform ... while reducing costs. Photo - ... Care Organization is the ACO operating entity of ... is to be the premier integrated health care ...
(Date:9/17/2014)... Fla. , Sept. 17, 2014   myMatrixx, a pharmacy ... today that Business Insurance magazine has awarded ... distinction for the third year in a row. ... effort of Business Insurance  and the Best Companies ... is open to all publicly or privately-held insurance industry ...
(Date:9/17/2014)... Sept. 17, 2014  NuView Life Sciences, Inc. ... and collaboration agreement with Otsuka Pharmaceutical Co., Ltd. ... genomic-based diagnostic biomarker to detect cancers of the ... other future diagnostic-imaging applications. NuView retains all rights ... and in-vitro urine screen applications. Under ...
Breaking Medicine Technology:Physician Direct Accountable Care Organization Selects Lightbeam Health to Enable Better Care at a Lower Cost 2Physician Direct Accountable Care Organization Selects Lightbeam Health to Enable Better Care at a Lower Cost 3myMatrixx Honored with "Best Places to Work in Insurance" Award 2NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 2NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 3NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 4NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 5
... 6 Reportlinker.com announces that a new ... catalogue. , Reportlinker Adds Gilead ... http://www.reportlinker.com/p0151769/Reportlinker-Adds-Gilead-Sciences-Inc-PharmaVitae-Profile.html , Introduction , This ... for Gilead in the prescription pharmaceutical sector. ...
... Oct. 6 Centocor Ortho Biotech Inc. and Schering-Plough ... European Commission has approved SIMPONI(TM) (golimumab) as a once-monthly, ... arthritis (RA), active and progressive psoriatic arthritis (PsA) and ... the European Union, SIMPONI is approved as a 50 ...
Cached Medicine Technology:Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile 2Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile 3Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile 4SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 2SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 3SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 4SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 5SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 6SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 7SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 8SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 9SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 10
... Single use curved circular ... and titanium staples., ,The ... stapler is used throughout the ... of end-to-end, end-to-side and side-to-side ...
The Auto Suture™ EEA™ reusable stainless steel sizer set has application in intestinal, colorectal and esophageal surgery to help evaluate the diameter of tubular structures....
... is synthesized in the parafollicular C-cells of ... secretory granules. The major action of calcitonin ... inhibiting osteoclast activity, resulting in decreased mobilization ... is most evident in conditions associated with ...
... The pHEM-ALERT® test provides a method for ... The pHEM-ALERT test is comprised of a plastic ... color chart and a package insert. The plastic ... flat key. pHEM-ALERT is indicated for measuring vaginal ...
Medicine Products: